logo
Share SHARE
FONT-SIZE Plus   Neg

Knight Capital To Cut About 5% Jobs After Restructuring

U.S. brokerage Knight Capital Group Inc. (KCG), in a filing on Monday, said it will reduce its worldwide workforce by approximately 5 percent as part of its corporate restructuring, which was aimed to lower operating expenses and improve financial performance.

In connection with the restructuring, Knight expects to incur a total estimated pre-tax charge between $9 and $11 million in its first quarter.

In a filing with the Securities and Exchange Commission or SEC, Knight Capital said that on January 30 it completed the restructuring, which was undertaken in an effort to combine its voice and electronic sales teams and as a result of the winding-down of its correspondent clearing initiative.

The firm has given notification to employees directly affected by the workforce reduction, and they will be provided with severance payments and specified benefits.

According to the company, the charges would include employee severance and other employee benefit costs between $8 and $10 million, and capitalized software write-down of approximately $1 million. It is also expected that cash expenditures will be between $4 and $5 million.

Knight said it expects that there will be additional costs related to the winding-down of its correspondent clearing initiative but such costs cannot be determined at this time.

Knight Capital closed Monday's trading at $3.68, down $0.04 or 1.08 percent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT